Dermavant

Developer of small molecule based therapeutics for the treatment of inflammatory skin diseases

placePhoenix, Arizona, United States calendar_todayFounded 2016 groups73 employees language dermavant.com

Registered entities

Investor mix

2 investors on record; lead investors include Marathon Asset Management, NovaQuest Capital Management.

Investor typeCountShare
Private equity150%
Other / undisclosed150%
Coming soon